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Abstract: To ensure their survival, microbial pathogens
have evolved diverse strategies to subvert host immune
defenses. The human retrovirus HIV-1 has been proposed
to hijack the natural endocytic function of dendritic cells
(DCs) to infect interacting CD4 T cells in a process termed
trans-infection. Although DCs can be directly infected by
certain strains of HIV-1, productive infection of DCs is not
required during trans-infection; instead, DCs capture and
internalize infectious HIV-1 virions in vesicles for later
transmission to CD4 T cells via vesicular exocytosis across
the infectious synapse. This model of sequential endocy-
tosis and exocytosis of intact HIV-1 virions has been
dubbed the ‘‘Trojan horse’’ model of HIV-1 trans-infection.
While this model gained rapid favor as a strong example
of how a pathogen exploits the natural properties of its
cellular host, our recent studies challenge this model by
showing that the vast majority of virions transmitted in
trans originate from the plasma membrane rather than
from intracellular vesicles. This review traces the experi-
mental lines of evidence that have contributed to what
we view as the ‘‘rise and decline’’ of the Trojan horse
model of HIV-1 trans-infection.
Introduction
Dendritic cells (DCs) play a central role in initiating the adaptive
immune response that counters pathogen infection. Immature DCs
patrol the peripheral mucosal tissues, searching for unwanted
intruders. Once a pathogen is sensed, captured, and internalized,
DCs undergo a maturation process and migrate to the regional
lymph nodes. Meanwhile, the internalized pathogens are processed
into antigenic peptides, and co-stimulatory molecules are expressed
on the cell surface, readying these professional antigen-presenting
cells for effective T-cellstimulation [1]. To performtheir key sentinel
function, DCs express a repertoire of pathogen recognition
receptors, including Toll-like receptors and C-type lectin receptors.
Toll-like receptors relay pathogen alert signals to DCs through
intracellular signaling pathways, culminating in both cellular
maturation and cytokine production [2,3]. C-type lectin receptors
recognize specific carbohydrate structures on these pathogens and
internalize them for degradation in lysosomal compartments, thus
initiating the process of antigen presentation [4,5].
Pathogens have evolved various means to escape the host
immune response by subverting the function of DCs. HIV-1 excels
in this capacity. Like many other microbial pathogens, HIV-1
interferes with Toll-like receptor signaling, impairing the secretion
of antiviral and inflammatory cytokines needed for the develop-
ment of an effective immune response [6,7]. HIV-1 also likely uses
DCs as a cellular ferry to reach one of its major targets, CD4 T
cells, located deep within the mucosa or in lymph nodes. HIV-1
can also directly infect and replicate in Langerhans cells (LCs) and
other myeloid DCs [8], although this infective process is much less
robust than that in CD4 T cells and seems to require higher viral
input [9]. Nevertheless, new virions budding from infected DCs
can help provide an ‘‘infectious beachhead’’ for subsequent spread
to CD4 T cells. In addition to replicating at low levels in DCs,
HIV-1 has been proposed to exploit these cells for a novel form of
viral spread involving the initial capture and internalization of
intact virions, followed later by the transfer of virions across
synapses formed by CD4 T cells scanning the DCs for cognate
antigen. This mechanism of viral spread is termed trans-infection.
Although direct evidence of trans-infection in vivo is lacking,
numerous in vitro observations suggest that such capture and
transfer of virions to permissive cells is advantageous for the virus,
in particular when quantities of infectious particles are limiting. In
early studies of ex vivo tissue explants, most HIV-1 replication was
observed within DC–T-cell conjugates [10,11,12]. DCs added to
peripheral blood mononuclear cells also greatly enhance HIV-1
replication. In these cocultures, most virions originate from T cells,
suggesting that DCs contribute in an indirect manner to overall
viral production [13].
The mechanism underlying this DC-dependent enhancement of
HIV infection remained unknown until the discovery of DC-
specific intercellular adhesion molecule-grabbing non-integrin
(DC-SIGN) [14]. DC-SIGN is a C-type lectin receptor expressed
by mucosal DCs and DCs derived in vitro from monocytes or
CD34 stem cells [14,15] and a subset of macrophages [16,17].
DC-SIGN binds with high affinity to the HIV-1 envelope protein
gp120 but, unlike CD4, does not trigger viral fusion. Instead, this
interaction promotes efficient virion capture [18,19]. These
captured virions are subsequently transmitted in trans to interacting
CD4 T cells [18]. Thus, DCs facilitate productive infection of
CD4 T cells while not serving as hosts for viral replication. Further
studies indicated that trans-infection involved internalization of
virions into an endocytic compartment [20,21]. Virion-containing
vesicles were later exported to the cellular synapses formed
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rise to the widely accepted concept of the ‘‘Trojan horse’’ model of
trans-infection in which exocytosis of virion-laden vesicles into the
synapse promoted highly efficient infection of CD4 T cells.
Diversity of DC Receptors Involved in trans-
Infection
DC-SIGN, the most-studied C-type lectin receptor that
captures HIV-1 virions, is a calcium-dependent lectin that binds
the HIV envelope with an affinity similar to that of CD4 [19]. The
C-terminal domain of DC-SIGN interacts with unknown
carbohydrate structures on gp120 [4,22,23,24]. Expression of
DC-SIGN in the lymphoblastoid cell line Raji (Raji-DC-SIGN),
originally mistaken for the monocyte-type line THP-1, is sufficient
to promote trans-infection of T cells [18,25]. However, whether
DC-SIGN is important in vivo remains controversial. Some
reports indicate that trans-infection of T cells by DCs derived in
vitro from monocytes (MDDCs) involves DC-SIGN
[9,18,20,26,27], while other studies suggest the involvement of
alternative C-type lectin receptors [16,28,29,30]. DC-SIGN is
expressed in vivo by some immature DCs located in mucosa
within the lamina propria [31]. Nevertheless, further studies are
needed to sort out the precise role of DC-SIGN versus other
receptors in the capture of HIV-1 virions by these DCs.
Other C-type lectin receptors, such as langerin and mannose
receptors, are at least equally important for gp120 binding to
epithelial DCs [32,33,34]. In freshly isolated skin LCs, langerin
binds gp120. In dermal DCs, binding involves mannose receptors.
Interestingly, when dermal DCs migrate out of skin explants, C-
type lectin receptors are down-regulated, and gp120 binding
occurs predominantly through CD4 [33]. Direct evidence of trans-
infection mediated by mannose receptors in DCs is lacking, but in
macrophages, these receptors appear to play an important role in
the trans-infection of CD4 T cells [35]. Conversely, capture of
HIV-1 by langerin expressed by LCs does not lead to CD4 T-cell
infection in trans [9]. Instead, langerin-bound virions are rapidly
cleared, especially with low viral input. Inhibition of HIV-1
binding to langerin with a newly developed anti-langerin antibody
or with mannan, a soluble general inhibitor for C-type lectin
receptors, markedly increases viral replication in cocultures of T
cells and epithelial LCs. This phenotype sharply contrasts with
trans-infection mediated by DC-SIGN on MDDCs, suggesting that
langerin and DC-SIGN may, in fact, mediate opposite fates for
HIV-1 virions. However, caution is warranted when comparing
results from ex vivo LCs and in vitro derived DCs. LCs derived in
vitro from CD34-expressing precursor cells, like MDDCs, mediate
efficient trans-infection of T cells despite expression of langerin
[36]. The use of higher viral inputs in these later experiments
might have overwhelmed the apparent protective function of
langerin. Interestingly, maturation of LCs with lipopolysaccharide
and TNF-a, although only slightly reducing langerin expression,
greatly increased the ability of these cells to support trans-infection
[36], even at low viral inputs [37]. Further follow-up studies are
required to better characterize the intriguing potential ‘‘clearing
function’’ of langerin in immature LCs and to understand why this
protective activity is diminished during LC maturation.
Some HIV-1 Virions Are Rapidly Internalized by
DCs, While Others Remain at the DC Surface
As part of their normal function, DCs internalize pathogens and
process proteins from these organisms into small antigenic peptides
for subsequent presentation to CD4 T cells on MHC-II receptors.
Typically, immature DCs display high levels of endocytic capacity
while mature DCs are characterized by efficient antigen
processing and presentation. Early in vitro and ex vivo studies
supported the notion that DCs internalize structurally intact HIV-
1 virions into large vacuolar structures [38,39,40]. At least some of
these structures correspond to internal vesicles based on lack of co-
staining with cationized ferritin [41] or ruthenium red [30], a
small membrane-nonpermeable dye that binds to carbohydrates at
the plasma membrane [42,43]. Surprisingly, mature MDDCs
harbor many more intact HIV-1 virions than immature MDDCs
[41]. Numerous intact virions are found in mature MDDCs within
large vesicles adjacent to the nucleus. In immature DCs, only a few
virion-laden vesicles are detected, usually at the periphery of the
DC. Virion internalization involves clathrin-dependent endocyto-
sis based on visualization of virions within both clathrin-coated pits
and internalized clathrin-coated vesicles [41,44]. However, some
virions remain detectable at the plasma membrane, notably within
deep folds of the plasma membrane [30,44] or between dendrites
[45]. Surface-bound virions are also readily observed on LCs
emigrating from vaginal epithelia [46]. In LCs isolated from skin
biopsies and subsequently loaded with HIV-1, virions colocalize
with Langerin at the cell surface and in Birbeck granules [9]. The
latter are LC-specific cytoplasmic organelles likely involved in
antigen processing [47].
In mature MDDCs, the compartment harboring HIV-1 virions
shares certain features with the late endosome or the multivesic-
ular body (MVB), but other features differentiate these structures
from classical late endosomes or lysosomes [44,45,48]. Specifically,
this compartment contains the tetraspanin receptors CD81,
CD82, and CD9 but contains little CD63 and no LAMP-1,
EEA-1, or TGN46, markers for lysosomes, early endosomes, and
trans-Golgi networks, respectively [44,49]. Immature MDDCs
lack these structures, suggesting that mature and immature
MDDCs may exhibit different intracellular trafficking patterns
for HIV-1 virions [45]. In this regard, immature DCs may
reorganize their endocytic compartments upon interaction with
HIV-1 virions [44], perhaps due to triggering of DC maturation
via stimulation of Toll-like receptor 8 [7].
Upon interaction with T cells, HIV-1-loaded MDDCs redis-
tribute virion-containing vesicles to the DC–T-cell junctions
[21,44,48], and CD4, CXCR4, and CCR5 are similarly recruited
to the T-cell face of the synapse [21]. Further evidence of HIV-1
virions localizing within the intracellular space between the
contact zone of T cells and MDDCs [30] or emigrant LCs [46]
is found in electron microscopic studies. The cell–cell contact zone
that facilitates HIV-1 transmission by locally concentrating virions
and viral receptors was termed the ‘‘infectious synapse’’ (for
review, see [50,51]). Together, these findings argued in favor of the
Trojan horse model, in which HIV-1 virions tap into an endocytic-
exocytic process of DCs to mediate trans-infection of CD4 T cells
[21,30,44,45,52].
HIV-1 Virions Transmitted in trans to CD4 T Cells
Originate from the DC Surface
Seeking to better understand the events involved in HIV-1 trans-
infection, we tested the effects of soluble CD4 (sCD4). This agent
selectively neutralizes gp120 on surface-bound virions while not
altering internalized virions. To our surprise, sCD4 completely
inhibited HIV-1 trans-infection [36], raising the possibility that the
surface-bound virions, rather than internalized virions, represent
the major source of virus for trans-infection. To exclude possible
unappreciated effects of sCD4, we also inactivated surface-bound
virions with pronase. Again, trans-infection was abrogated by the
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MDDCs and CD34-derived LCs. These findings implicating
surface virions in trans-infection (Figure 1) are also supported by
two prior studies employing cell-impermeable inhibitors [53,54],
which prevent viral fusion by disrupting the viral envelopes. In the
first study, amphibian-derived peptides effectively inhibited trans-
infection when applied to HIV-1-loaded MDDCs and thoroughly
washed out before incubation with target cells [53]. Van
Coppernolle et al. raised for the first time the possibility that
virions transferred from DCs originate from the cell surface.
However, in an attempt to reconcile these findings with the
strongly prevailing Trojan horse model, the authors proposed an
alternative explanation, in which HIV-1 virions were targeted by
small quantities of residual peptide remaining after the wash
procedure at a time when vesicle contents are released into the
synaptic cleft. In our studies evaluating possible ‘‘carryover’’ effects
of sCD4, we find that sCD4 only inactivates virions accessible at
the time of sCD4 treatment and not virions loaded after the
application of sCD4 and its removal by washing [36]. In the other
study, a novel topical microbicide candidate called SAMMA [55],
which appears to interrupt HIV-1 gp120/gp41 fusion, also
potently inhibited trans-infection of T cells by MDDCs [54]
without gaining entry into cells. Together, these findings are
consistent with our conclusion that trans-infection is primarily
mediated by surface-bound rather than internalized HIV virions.
The only situation in which a few internalized virions may find
their way to the infectious synapse and infect interacting T cells in
trans is in the context of specific antigen recognition by interacting
CD4 T cells. Recognition of antigens loaded on MHC-II at the
DC surface by the appropriate T-cell receptors triggers the
rearrangement of the MVB, promoting additional MCH-II
receptor translocation from the MVB to the DC surface [56].
Staphyloccal enterotoxin B mimics this sequence of events by
cross-linking the variable region of the TCR b-chain of T cells and
MHC-II molecules [57]. In this setting and this setting alone, we
detected very low levels of transfer of internalized virions to
interacting CD4 T cells. However, this transfer represents less than
1% of the total transfer events; 99% or more of virions mediating
trans-infection continue to derive from the cell surface [36].
Nevertheless, it is intriguing to consider the possibility that this
transfer might play a role in the preferential and rapid depletion of
HIV-1-specific CD4 T cells that occurs in HIV infection [58].
The Rise and Decline of the Trojan Horse Model
for trans-Infection
The Trojan horse metaphor became popular with the report of
Steinman et al., which showed that the potency of DCs in
stimulating trans-infection of CD4+ T cells [10]. This metaphor
emphasized that DCs, a trusted party in the immune system, could
actually carry an infectious agent to CD4+ T cells, leading to their
destruction. The mechanism was refined later with the discovery
of DC-SIGN as an HIV-1 gp120 binding protein [18]. The
analogy to the Trojan horse became even more striking when
Kwon et al. [20] suggested that HIV-1 virion internalization was
required for trans-infection of T cells. The strongest support for this
conclusion was the ability of both immature MDDCs and Raji-
DC-SIGN cells loaded with R5-tropic HIV-1 virions to trans-infect
T cells despite the inactivation of surface-bound virions with
trypsin. While these experiments included appropriate controls
indicating that the trypsin had efficiently inactivated surface-
bound virions, the study did not exclude direct infection of
immature MDDCs as the source of viral reporter expression. To
take this analysis one step further, we performed similar
experiments with reporter viruses encoding two distinct epifluor-
escent proteins, allowing clear distinction between signals deriving
from DCs and T cells [36]. Again, we observed that inactivation of
surface-bound HIV virions completely abrogated trans-infection by
MDDCs. Direct infection of Raji-DC-SIGN cells could not readily
explain the results obtained, as these cells are only weakly
susceptible to HIV-1 infection [59]. However, two recent reports
employing trypsin or pronase treatment of Raji-DC-SIGN cells
suggest that trans-infection by these cells involves virions located at
the cell surface [29,30]. The initial study also concluded that Raji
cells expressing DC-SIGN with a truncation of its cytoplasmic
domain failed to trans-infect T cells. However, the large truncation
in DC-SIGN might also have affected formation of the infectious
synapse, which seems to require DC-SIGN or the effective
migration of DC-SIGN-bound virions on the DC surface to the
infectious synapse [27]. Of note, a subsequent study highlights
how point mutations that compromise the internalization of DC-
SIGN do not impair trans-infection [60].
Striking time-lapse microscopic images of internalized virions
being delivered to interacting CD4 T cells via the infectious
synapse added further momentum to the Trojan horse model [21].
However, because of the nature of these experiments, it was not
possible to determine if the vesicles moving to the infectious
synapse ferried infectious virions. The recruitment of these virions
to the synapse was also observed after trypsin digestion of HIV-
loaded DCs, although data on the completeness of surface virion
inactivation were not presented.
In subsequent papers, proteolytic digestion remained the
principal tool for eliminating surface virions as a source of virus-
mediating trans-infection [29,37,61]. The effectiveness of these
proteases varied greatly from study to study (Table 1). Numerous
parameters influence protease effectiveness, including the type of
protease used, the time and temperature of incubation, and the
complexity of the cell membrane. Appropriate controls are
essential to ensure that all surface-bound virions are in fact
inactivated. Cleavage of DC-SIGN receptors at the surface of
MDDCs has been used as one control to monitor protease
effectiveness [30]. However, despite a decrease in surface
expression of DC-SIGN, most surface-bound virions (87%)
remained attached to mature MDDCs. Thus, DC-SIGN cleavage
is not a reliable control for proteolytic inactivation of surface
virions, particularly in mature MDDCs. Accordingly, trans-
infection experiments employing this criterion for virion inactiva-
tion must be interpreted with great caution. Internal controls, as
initially described by Kwon et al. [20], remain the best approach.
These authors used two reporter viruses, one internalized and the
second bound to the DC surface, to serve as an internal control for
the completeness of inactivation of surface-bound virions. When
we performed similar experiments with reporter viruses that
permit the distinction of signal emanating from productively
infected DCs and actual trans-infection of T cells, we did not
observe any contribution of internalized virions in DCs to the
trans-infection process under conditions in which surface virions
were fully inactivated with pronase [36].
A major drawback of protease treatment of the cell surface is its
relative lack of specificity for bound HIV-1 virions. Key
components of the infectious synapse could be digested, resulting
in altered or delayed synapse formation. The use of more specific
membrane-impermeable inhibitors, such as sCD4 and HIV-1-
neutralizing antibodies, avoids these complications. Two studies
with these agents have appeared [36,62]. We reported that sCD4
treatment of MDDCs and CD34-derived LCs loaded with HIV
virions fully abrogated trans-infection of T cells [36]. Ganesh et al.
used neutralizing antibodies but found no effect on HIV trans-
PLoS Pathogens | www.plospathogens.org 3 June 2008 | Volume 4 | Issue 6 | e1000051Figure 1. Models for trans-Infection of CD4 T cells by DCs. After capture by DCs, HIV-1 virions are either internalized or remain at the cell
surface, possibly at the tips of dendrites or within extensively folded invaginations of the plasma membrane. A. In the prevailing Trojan horse model
of HIV trans-infection, trans-infection is primarily mediated by internalized virions. B. In the new model, surface-bound HIV-1 virions are mainly
responsible for trans-infection. Virions possibly surf the surface of the DCs on lipid rafts that collect at the infectious synapse to promote effective
delivery to interacting CD4 T cells.
doi:10.1371/journal.ppat.1000051.g001
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neutralization of surface-bound virions was controlled internally,
the effectiveness of antibody neutralization of surface-bound
virions was not tested. Rather, neutralization of cell-free virions
was presented. At the highest concentration of antibody used,
Ganesh et al. achieved only 70% neutralization. Even higher
quantities of antibody might be required to neutralize MDDC-
bound virions, compared to free virions. Indeed, our preliminary
data support this notion. When we have tested higher concentra-
tions of neutralizing antibodies that achieve full inactivation of
surface-bound virions, we observe that HIV-1 trans-infection is
completely abrogated (unpublished data).
Recently, a twist on the Trojan horse model emerged in a study
suggesting that HIV-1 virions in immune complexes may recover
their infectivity after capture by immature MDDCs and release of
the bound antibodies within the acidified endocytic compartment
[63]. However, no data were presented to clearly show that this
recovery of infectivity was occurring in an internal acidified
compartment rather than at the plasma membrane. More studies
are warranted to examine trans-infection in the context of
opsonized HIV-1 virions.
Internalization Is Likely a Dead End for trans-
Infection
The fact that virions are almost exclusively transmitted from the
DC surface implies that virion internalization is chiefly a dead end
for infectious virions. Several factors influencing the internaliza-
tion of HIV-1 virions might affect their likelihood to trans-infect T
cells. Such factors include the state of DC activation and
maturation, the time elapsing between virion capture by DCs
and contact with interacting T cells, and the nature of receptors
that mediate binding of HIV-1 virions.
External molecules are taken up in DCs via multiple pathways,
including phagocytosis, macropinocytosis, and receptor-mediated
endocytosis via clathrin-coated pits and caveolae. DC differenti-
ation and maturation are associated with a decline in endocytic
activity, particularly macropinocytosis [1]. This decrease in
internalization with maturation might leave more intact virions
at the surface of mature DCs and could contribute to the enhanced
ability of mature DCs to trans-infect T cells [21,36,37,45,64,65,66].
Increased interactions between mature DCs and T cells may also
facilitate virion transfer [21,64]. Finally, differences in the nature of
the compartment harboring virions could play a role. Large vesicles
filled with intact HIV-1 virions are observed in mature DCs
[30,41,48] but not in immature cells [41]. Whether these virus-filled
structures are in fact contiguous with the plasma membrane is
unknown, but this is certainly possible, given the exceedingly
complex 3-D architecture of the DC plasma membrane. In this
regard, two recent studies of HIV-1 budding in macrophages
indicate that virions accumulating in apparently intracellular
vacuolar structures are, in fact, budding from an extensively folded
region of the plasma membrane [43,67]. These structures, which are
present in infected and uninfected macrophages, seem to be stable
and could correspond to specialized compartments of the plasma
membrane [67]. In mature MDDCs, images of virus-filled structures
in direct continuity with the DC surface [30,41] were initially
interpreted as areas of active virion internalization or as exocytic
vacuoles releasing captured virions. Such structures might in fact
correspond to deep invaginations of the plasma membrane. This
possibility is bolstered by the fact that in mature MDDCs ,80% of
vacuolesharboringthevirionsremainaccessibletosmallmembrane-
impermeable tracer proteins like horseradish peroxidase applied at
4uC [44]. Future studies will likely better define the nature of these
virion collection depots and determine whether these virions in fact
reside in internal vacuoles or instead represent complex invagina-
tions of the plasma membrane.
The time elapsing between virion capture by DCs and contact
with interacting T cells may also affect the efficiency of trans-
infection. In initial studies, virions captured by Raji-DC-SIGN and
MDDCs retained their infectivity for several days [18,68,69].
However, more recent studies suggest that virions remain active
fortrans-infection foronlya few hoursaftercapture [30,36,48,59,60].
Low levels of direct HIV-1 infection of Raji-DC-SIGN and
immature MDDCs could provide an explanation for the early
reports of persistent trans-infection [30,48,59]. Currently, virion
inactivation/degradationafterDCcaptureisbelievedtounderliethe
rapid decline in trans-infection [30,37,48,69]. However, rapid
internalization of HIV-1 virions might also contribute to this quick
decline in trans-infection, as seen in macrophages [35]. Treatment of
macrophages withendocytosis inhibitors,suchascytochalasin D and
Table 1. Variable Effects of Protease Treatment on HIV trans-Infection.
Cells Inhibition of trans-Infection (% of Untreated) Treatment Controls
a Reference
Raji-DC-SIGN ,35% Trypsin Internal controls [20]
91% Trypsin Cleavage of DC-SIGN [30]
,90% Pronase Cleavage of DC-SIGN [29]
Immature MDDCs ,45%–50% Trypsin Internal controls [20]
40%–50% Trypsin Cleavage of DC-SIGN [30]
48%–51% Pronase Cleavage of DC-SIGN [30]
99% Pronase Internal controls [36]
Mature MDDCs 20% Trypsin Cleavage of DC-SIGN [30]
24%–35% Pronase Cleavage of DC-SIGN [30]
99% Pronase Internal controls [36]
Immature CD34-derived LCs ,85% Trypsin Not presented [37]
Mature CD34-derived LCs ,83% Trypsin Not presented [37]
Cord blood–derived DCs 0% Pronase Cleavage of DC-SIGN [29]
aControls used to assess the effectiveness of proteolytic digestion in removing surface-bound virions.
doi:10.1371/journal.ppat.1000051.t001
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virions. These agents have not yet been tested in the context of trans-
infection of T cells by DCs. Interestingly, the use of inhibitors that
impair intracellular trafficking and/or acidification oftheendosomes
appear to exert only minimal effects on trans-infection [30,59],
although conflicting results have been obtained with the vacuolar
ATPase inhibitor concanamycin A [20,59]. Surface molecules other
than C-type lectins could also influence the efficiency of trans-
infection[61].Forexample,expressionofCD4receptorsinRajicells
increases internalization of virions and reduces trans-infection.
Conversely, expression of Nef in MDDCs and neutralization of
CD4 by antibodies decrease available surface CD4 and are
associated with increases in trans-infection. Collectively, these studies
suggest that virion internalization negatively regulates trans-infection
and are consistent with surface-bound virions forming the principal
source of virions mediating trans-infection.
Future Directions
The finding that trans-infection of T cells by DCs involves
primarily surface-bound virions argues that future research should
be refocused on how HIV-1 hijacks the plasma membrane rather
than the intracellular trafficking pathway as suggested by the
original Trojan horse model. Unraveling how these virions are
recruited to the infectious synapse is crucial. The presence of C-
type lectin receptors in lipid rafts [70] suggests that HIV-1 virions
likely reach the infectious synapse by ‘‘surfing’’ the surface of the
plasma membrane of DCs on lipid rafts. Further studies to
characterize the domain(s) of DC plasma membrane that serves as
a source of infectious virions could reveal some similarities with the
compartments in which HIV-1 buds in macrophages. Since that
internalization seems to be mostly a dead end for infectious
virions, elucidating how HIV-1 manages to remain at the cell
surface poised for transfer in trans will be important. Finally, our
new model suggests that in vivo transmission of virions captured
by DCs to T cells is likely to be far more sensitive to attachment
inhibitors and neutralizing antibodies than previously anticipated.
Only time will tell whether this fact can be therapeutically
exploited.
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